Literature DB >> 16212903

CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice.

Weibing Qin1, Jianwei Jiang, Qiaoer Chen, Ning Yang, Yifeng Wang, Xiangcai Wei, Ruqiang Ou.   

Abstract

Oligodeoxynucleotides (ODN) containing unmethylated CpG dinucleotides in contexts of unique sequence (CpG motifs) is active as adjuvant in induction of cellular and humoral immune responses in young mice. To date, there are only limited reports about effect of CpG ODN on immune responses against hepatitis B (HB) infection in aged mice. Our studies demonstrated there were significant increases in secreting of total anti-HB IgG, IgG1 and IgG2a, as well as of IL-12 and IFN-gamma, when CpG ODNs were injected together with hepatitis B antigen in aged mice. Moreover, CpG ODN could stimulate proliferation of spleen lymphocytes in a dose-dependent manner. Taken together, the results we obtained indicate that the adding of CpG ODN into the vaccine antigen might be useful in development of more effective vaccination for inducing anti-HB virus responses in the elderly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16212903

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  11 in total

1.  A novel adjuvant for vaccine development in the aged.

Authors:  Edward L Morgan; Marilyn L Thoman; Sam D Sanderson; Joy A Phillips
Journal:  Vaccine       Date:  2010-10-19       Impact factor: 3.641

Review 2.  CpG DNA as a vaccine adjuvant.

Authors:  Christian Bode; Gan Zhao; Folkert Steinhagen; Takeshi Kinjo; Dennis M Klinman
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 3.  TLR-based immune adjuvants.

Authors:  Folkert Steinhagen; Takeshi Kinjo; Christian Bode; Dennis M Klinman
Journal:  Vaccine       Date:  2010-08-14       Impact factor: 3.641

4.  Factors that may impact on immunosenescence: an appraisal.

Authors:  Joseph Ongrádi; Valéria Kövesdi
Journal:  Immun Ageing       Date:  2010-06-14       Impact factor: 6.400

5.  Development of effective vaccines for old mice in a tumor model.

Authors:  David N Posnett; Manuel E Engelhorn; Yun Lin; Taha Merghoub; Fei Duan; Jedd D Wolchok; Alan N Houghton
Journal:  Vaccine       Date:  2008-12-25       Impact factor: 3.641

Review 6.  A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderly.

Authors:  Yoshiko Fukuyama; Yorihiko Ikeda; Junichiro Ohori; Gen Sugita; Kazuyoshi Aso; Keiko Fujihashi; David E Briles; Jerry R McGhee; Kohtaro Fujihashi
Journal:  Immune Netw       Date:  2015-02-17       Impact factor: 6.303

7.  CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection.

Authors:  Jonathan B Angel; Curtis L Cooper; Jennifer Clinch; Charlene D Young; Andreane Chenier; Karl G Parato; Michael Lautru; Heather Davis; Donald W Cameron
Journal:  J Immune Based Ther Vaccines       Date:  2008-08-12

Review 8.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

9.  Immunity, ageing and cancer.

Authors:  Evelyna Derhovanessian; Rafael Solana; Anis Larbi; Graham Pawelec
Journal:  Immun Ageing       Date:  2008-09-24       Impact factor: 6.400

10.  The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice.

Authors:  Gee Jun Tye; Kyriaki Ioannou; Eunice Amofah; Ruby Quartey-Papafio; Samantha J Westrop; Pramila Krishnamurthy; Alistair Noble; Phillip M Harrison; Karin M L Gaensler; Linda D Barber; Farzin Farzaneh
Journal:  Immun Ageing       Date:  2015-06-25       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.